Insights+

Insights+: EMA Marketing Authorization of New Drugs in June 2024

Insights+: EMA Marketing Authorization of New Drugs in June 2024

Shots:   The EMA granted Positive Opinion to 4 Biologics and 3 New...

Disease of the Month – Small Cell Lung Cancer

Disease of the Month – Small Cell Lung Cancer

Shots:  Small cell lung cancer (SCLC) aka Oat cell carcinoma is a rare &...

Know Your Investor: Invus (July’24 Edition)

Know Your Investor: Invus (July’24 Edition)

Shots:    Backed with an evergreen investment strategy, Invus makes investmen...

Insights+: The US FDA New Drug Approvals in June 2024

Insights+: The US FDA New Drug Approvals in June 2024

Shots:    PharmaShots has compiled a list of US FDA-approved drugs...

Insights+ Key Biosimilars Events of June 2024

Insights+ Key Biosimilars Events of June 2024

Shots:    Biosimilars are developed to be highly similar versions o...

PharmaShots' Key Highlights of Second Quarter 2024

PharmaShots' Key Highlights of Second Quarter 2024

Shots: The second quarter of 2024 highlights major acquisitions in the pharma and...

Image